Stanley Choy
Chief Financial Officer at Alphina Therapeutics | Greenwich, Connecticut, United States
Stanley Choy’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
Co-Chairman, Board Member and Treasurer at BioCT - Connecting CT's Bioscience Community in January 2012 - Present
Co-founder and Partner at SHY Therapeutics, LLC in January 2014 - Present
Chief Financial and Business Officer at Qx Therapeutics Inc in January 2017 - Present
State University of New York College at Plattsburgh, BS, January 1980 to January 1984
Syracuse University - Martin J. Whitman School of Management, MBA, January 1986 to January 1988
At Alphina Therapeutics we are working to fulfill the promise of precision oncology — higher response rates for more patients. Our approach combines two cutting-edge scientific breakthroughs: First, our drug candidates use antibody-drug conjugate (ADC) technology to deliver potent NAMPT inhibitor payloads directly to the tumor. By disrupting cancer’s energy supply, these next-generation payloads are designed to kill both dividing and non-dividing tumor cells. Importantly, our therapies can be effective even when other ADCs, including Topo1-based treatments, no longer work. Second, we have developed a proprietary test that identifies the patients most likely to benefit from NAMPT inhibitors. Our goal is simple: match the right treatment with the right patient to achieve superior outcomes. Unlike most targeted treatments that help relatively few patients, ours could benefit more than 450,000 people each year in the U.S. alone. Our mission is to apply these breakthroughs to deliver smarter, more effective cancer therapies to the patients who urgently need them.
Discover more about Alphina TherapeuticsCEO at Alphina Therapeutics
Chief Executive Officer at Alphina Therapeutics
(Oct 2024 – Present)
Chief Scientific Officer at Alphina Therapeutics
Advancing our novel ADC platform with a new payload class and a new approach to patient selection.
Drug discovery and development
Senior Director, Head of Biology at Alphina Therapeutics
(Dec 2025 – Present)
Alphina Corporate Development | ex-L.E.K.
Redefining precision oncology for ADCs with a novel payload
Biotech Executive, Independent Board Member, Serial Entrepreneur
Independent Board Chair at Alphina Therapeutics
(Oct 2024 – Present)
Sr. VP, Head of Medicinal Chemistry at Alphina Therapeutics: Retired! Currently SAB Member / working part time as consultant for Alphina
(Sr. VP Med Chem: Retired), currently SAB Member / consultant at Alphina Therapeutics
(Jun 2025 – Present)
What is Stanley Choy email address?
Email Stanley Choy at [email protected] and [email protected]. This email is the most updated Stanley Choy's email found in 2026.
How to contact Stanley Choy?
To contact Stanley Choy send an email to [email protected] or [email protected].
What company does Stanley Choy work for?
Stanley Choy works for Alphina Therapeutics.
What is Stanley Choy's role at Alphina Therapeutics?
Stanley Choy is Chief Financial Officer
What industry does Stanley Choy work in?
Stanley Choy works in the Pharmaceuticals industry.